Bellwether Advisors’s CareDx CDNA Stock Holding History

Bellwether Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-57	Closed	-$3K	–	430
2021 Q1	$3K	Sell	57 -1	-2%	-$78	﹤0.01%	323
2020 Q4	$4K	Buy	+58	New	+$3.36K	﹤0.01%	272

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bellwether Advisors's CDNA Position: Q2 2021 in Review

Bellwether Advisors sold out of CareDx (CDNA) in Q2 2021, closing a stake of 57 shares — an estimated $3K sold.

Bellwether Advisors first reported a position in CDNA in Q4 2020 and held it in 2 quarters. The position peaked at $4K in Q4 2020. 254 funds tracked by Wall St. Rank hold CDNA as of Q2 2021.

Bellwether Advisors reported no remaining CareDx position as of Q2 2021 after selling out during the quarter.
Bellwether Advisors sold 57 CareDx shares in Q2 2021, an estimated $3K.
Bellwether Advisors first reported a position in CareDx in Q4 2020 and held it in 2 quarters.
Bellwether Advisors's CareDx position peaked at $4K in Q4 2020.
254 funds tracked by Wall St. Rank held CareDx as of Q2 2021.

Based on Bellwether Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.